Development of specific CXCR4 inhibitors possessing high selectivity indexes as well as complete stability in serum based on an anti-HIV peptide T140. (Q39507572)

From Wikidata

Jump to navigation Jump to search

scientific article published on July 2001

Language	Label	Description	Also known as
English	Development of specific CXCR4 inhibitors possessing high selectivity indexes as well as complete stability in serum based on an anti-HIV peptide T140.	scientific article published on July 2001

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Development of specific CXCR4 inhibitors possessing high selectivity indexes as well as complete stability in serum based on an anti-HIV peptide T140. (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

author name string

Tamamura H

1

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Omagari A

2

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Hiramatsu K

3

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Gotoh K

4

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Kanamoto T

5

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Xu Y

6

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Kodama E

7

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Hattori T

9

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Yamamoto N

10

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Nakashima H

11

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Otaka A

12

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Fujii N

13

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

language of work or name

0 references

publication date

1 July 2001

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Bioorganic & Medicinal Chemistry Letters

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

14

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

1897-1902

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900323-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification of a major co-receptor for primary isolates of HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900323-7

7 January 2021

based on heuristic

inferred from DOI database lookup

HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900323-7

7 January 2021

based on heuristic

inferred from DOI database lookup

CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900323-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900323-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900323-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A small molecule CXCR4 inhibitor that blocks T cell line-tropic HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900323-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibitory mechanism of the CXCR4 antagonist T22 against human immunodeficiency virus type 1 infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900323-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900323-7

7 January 2021

based on heuristic

inferred from DOI database lookup

AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900323-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A small-molecule inhibitor directed against the chemokine receptor CXCR4 prevents its use as an HIV-1 coreceptor

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900323-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of in vitro and in vivo HIV replication by a distamycin analogue that interferes with chemokine receptor function: a candidate for chemotherapeutic and microbicidal application

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900323-7

7 January 2021

based on heuristic

inferred from DOI database lookup

HIV blocked by chemokine antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900323-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900323-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A low-molecular-weight inhibitor against the chemokine receptor CXCR4: a strong anti-HIV peptide T140.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900323-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Conformational study of a highly specific CXCR4 inhibitor, T140, disclosing the close proximity of its intrinsic pharmacophores associated with strong anti-HIV activity

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900323-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Interactions of an antimicrobial peptide, tachyplesin I, with lipid membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900323-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular parameters for the anti-human immunodeficiency virus activity of T22 ([Tyr5,12, Lys7]-polyphemusin II).

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900323-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacophore identification of a specific CXCR4 inhibitor, T140, leads to development of effective anti-HIV agents with very high selectivity indexes

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900323-7

7 January 2021

based on heuristic

inferred from DOI database lookup

p-Alkoxybenzyl Alcohol Resin and p-Alkoxybenzyloxycarbonylhydrazide Resin for Solid Phase Synthesis of Protected Peptide Fragments

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900323-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Production of high-titer helper-free retroviruses by transient transfection

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900323-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Pseudotyping with human T-cell leukemia virus type I broadens the human immunodeficiency virus host range

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900323-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900323-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Anti-human immunodeficiency virus activity of a novel synthetic peptide, T22 ([Tyr-5,12, Lys-7]polyphemusin II): a possible inhibitor of virus-cell fusion

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900323-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Marked increase in anti-HIV activity, as well as inhibitory activity against HIV entry mediated by CXCR4, linked to enhancement of the binding ability of tachyplesin analogs to CXCR4

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900323-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Purification and characterization of an avian myeloblastosis and human immunodeficiency virus reverse transcriptase inhibitor, sulfated polysaccharides extracted from sea algae

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900323-7

7 January 2021

based on heuristic

inferred from DOI database lookup

3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900323-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I studies of 2',3'-dideoxycytidine in severe human immunodeficiency virus infection as a single agent and alternating with zidovudine (AZT).

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900323-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization of stable Chinese hamster ovary cells expressing wild-type, secreted, and glycosylphosphatidylinositol-anchored human immunodeficiency virus type 1 envelope glycoprotein.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900323-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Infection of monocyte-derived macrophages with human immunodeficiency virus type 1 (HIV-1). Monocyte-tropic and lymphocyte-tropic strains of HIV-1 show distinctive patterns of replication in a panel of cell types

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900323-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Involvement of chemokine receptors in breast cancer metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900323-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0960-894X(01)00323-7

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39507572&oldid=2039703057"